Drawing for ROSALIND

USPTO serial 87157055

ROSALIND

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HUSSAIN, TASNEEM
Law office
TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ROSALIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James L. Scott

James L. Scott WARNER NORCROSS + JUDD LLP150 Ottawa Ave NW1500 Warner BuildingGRAND RAPIDS, MI 49503

Goods and services

ClassDescriptionStatusFirst use
009Computer software and computer application software for use by physicians to assist in selection of cancer treatment drugs; computer software and computer application software for use by physicians to generate output of cancer treatment drugs; Mobile application software to assist physicians in selection of cancer treatment drugs; mobile application software for use by physicians to generate output of cancer treatment drugsACTIVE—
016Printed publications, namely, reports for use by physicians to assist in selection of cancer treatment drugsACTIVE—
042Software as a service (SAAS) services featuring software to assist physicians in selection of cancer treatment drugs; software as a service (SAAS) services featuring software for use by physicians to generate output of cancer treatment drugs; providing temporary use of online non-downloadable software to assist physicians in selection of cancer treatment drugs; providing temporary use of online non-downloadable software for use by physicians to generate output of cancer treatment drugs; Providing a website featuring information about software for use by physicians to assist in selection of cancer treatment drugsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 18, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 18, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 2, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 2, 2019CNSISUSPENSION INQUIRY WRITTEN—
Jan 31, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 31, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jan 31, 2019CNSLSUSPENSION LETTER WRITTEN—
Jan 28, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Jan 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2019PETGPETITION TO REVIVE-GRANTED—
Jan 22, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Jul 17, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 17, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 17, 2018CNSISUSPENSION INQUIRY WRITTEN—
Feb 28, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 16, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 16, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Jan 16, 2018CNSLSUSPENSION LETTER WRITTEN—
Jan 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 8, 2018ALIEASSIGNED TO LIE—
Dec 20, 2017NREVNOTICE OF REVIVAL - E-MAILED—
Dec 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2017PETGPETITION TO REVIVE-GRANTED—
Dec 20, 2017PROATEAS PETITION TO REVIVE RECEIVED—
Jun 19, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jun 19, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 19, 2017CNSISUSPENSION INQUIRY WRITTEN—
Dec 12, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 12, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Dec 12, 2016CNSLSUSPENSION LETTER WRITTEN—
Dec 9, 2016DOCKASSIGNED TO EXAMINER—
Sep 7, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance